|
⚲
|
| Keith Crandell | |
|---|---|
| Firm | |
| Address | c/o Vizgen, Inc 150 Bear Hill Road Waltham, Ma 02451 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Vizgen Inc | 021-569582 | Director | 47.8 M of 50.0 M |
||
| Vizgen Inc | 021-560062 | Director | 3.5 M of 9.5 M |
||
| Cytrellis Biosystems Inc | 021-533919 | Director | 25.1 M of 32.1 M |
||
| Vizgen Inc | 021-527442 | Director | 107.6 M | ||
| Ultivue Inc | 021-519765 | Director | 3.3 M of 15.0 M |
||
| Vizgen Inc | 021-444596 | Director | 85.2 M of 105.2 M |
||
| Arbor Biotechnologies Inc | 021-420716 | Director | 215.0 M of 215.0 M |
||
| Vizgen Inc | 021-395106 | Director | 37.0 M of 37.0 M |
||
| Cytrellis Biosystems Inc | 021-385135 | Director | 50.0 M of 50.0 M |
||
| Quanterix Corp | 021-344019 | Director | 6.2 M of 6.5 M |
||
| Ultivue Inc | 021-343102 | Director | 26.5 M of 26.5 M |
||
| Nanosys Inc | 021-313618 | Director | 10.0 M of 15.0 M |
||
| Twist Bioscience Corp | 021-309072 | Director | 50.0 M of 85.0 M |
||
| Nanosys Inc | 021-295131 | Director | 7.5 M of 15.2 M |
||
| Ultivue Inc | 021-291239 | Director | 20.2 M of 20.5 M |
||
| Quanterix Corp | 021-288694 | Director | 8.5 M of 8.5 M |
||
| Arbor Biotechnologies Inc | 021-287829 | Director | 15.6 M of 15.6 M |
||
| Twist Bioscience Corp | 021-283322 | Director | 74.9 M of 75.0 M |
||
| 908 Devices Inc | 021-282653 | Director | 24.0 M of 24.0 M |
||
| Twist Bioscience Corp | 021-261615 | Director | 2.6 M of 2.6 M |
||
| Quanterix Corp | 021-260426 | Director | 45.6 M of 45.6 M |
||
| Twist Bioscience Corp | 021-255514 | Director | 61.0 M of 61.0 M |
||
| Adesto Technologies Corp | 021-247264 | Director | 2.2 M of 2.2 M |
||
| Adesto Technologies Corp | 021-247262 | Director | 12.4 M of 12.5 M |
||
| Adesto Technologies Corp | 021-247267 | Director | 0.8 M of 0.8 M |
||
| Twist Bioscience Corp | 021-241542 | Director | 37.0 M of 37.0 M |
||
| 908 Devices Inc | 021-239284 | Director | 11.6 M | ||
| Nanosys Inc | 021-235586 | Director | 5.0 M of 10.0 M |
||
| Twist Bioscience Corp | 021-218109 | Director | 26.0 M of 26.5 M |
||
| Pixelexx Systems Inc | 021-210914 | Director | 0.6 M of 0.9 M |
||
| Quanterix Corp | 021-208092 | Director | 1.0 M of 1.0 M |
||
| Boreal Genomics Inc | 021-204450 | Director | 18.0 M of 18.0 M |
||
| 908 Devices Inc | 021-201909 | Director | 7.0 M of 8.0 M |
||
| Twist Bioscience Corp | 021-199598 | Director | 9.1 M of 9.3 M |
||
| Adesto Technologies Corp | 021-191849 | Director | 5.0 M of 5.0 M |
||
| Ciespace Corp | 021-189562 | Director | 1.0 M of 1.0 M |
||
| Nanosys Inc | 021-187456 | Director | 15.0 M of 15.0 M |
||
| Adesto Technologies Corp | 021-185597 | Director | 1.1 M of 1.1 M |
||
| Adesto Technologies Corp | 021-183832 | Director | 14.0 M of 39.0 M |
||
| Adesto Technologies Corp | 021-182176 | Director | 1.0 M of 2.0 M |
||
| Nanosys Inc | 021-181817 | Director | 1.0 M of 1.0 M |
||
| Quanterix Corp | 021-174382 | Director | 2.0 M | ||
| Univa Corp | 021-173536 | Director | 10.4 M of 10.8 M |
||
| Permeon Biologics Inc | 021-170937 | Director | 2.5 M of 2.5 M |
||
| Quanterix Corp | 021-164739 | Director | 6.0 M | ||
| Adesto Technologies Corp | 021-163655 | Director | 17.4 M of 26.0 M |
||
| Newco LS15 Inc | 021-151570 | Director | 3.5 M of 3.5 M |
||
| Quanterix Corp | 021-148869 | Director | 2.5 M of 5.0 M |
||
| Nanosys Inc | 021-147240 | Director | 38.4 M of 38.4 M |
||
| Crystal is Inc | 021-144900 | Director | 4.6 M of 7.0 M |
||
| Adesto Technologies Corp | 021-144136 | Director | 3.5 M of 3.5 M |
||
| Crystal is Inc | 021-69963 | Director | 0.6 M of 1.1 M |
||
| Univa Corp | 021-80694 | Director | 2.0 M of 2.0 M |
||
| Adesto Technologies Corp | 021-101969 | Director | 14.0 M of 14.2 M |
||
| Arch Venture Management LLC | |||||
| Arch Venture Fund XIII LP | 021-504109 | Executive Officer | of 3.0 B |
3,309.7 | |
| Arch Venture Fund XII LP | 021-432243 | Executive Officer | 2.8 B of 2.9 B |
2,960.5 | |
| Arch Venture Fund Xi LP | 021-380955 | Executive Officer | 1.9 B of 1.9 B |
1,645.1 | |
| Arch Venture Fund X LP | 021-324494 | Executive Officer | 635.8 M of 675.0 M |
493.4 | |
| Arch Venture Fund X Overage LP | 021-324501 | Executive Officer | 635.8 M of 675.0 M |
530.4 | |
| Arch Venture Fund IX LP | 021-259517 | Executive Officer | 408.4 M of 550.0 M |
486.3 | |
| Arch Venture Fund IX Overage LP | 021-274831 | Executive Officer | of 450.0 M |
438.8 | |
| Arch Venture Fund VIII LP | 021-216149 | Executive Officer | 400.5 M of 400.5 M |
384.3 | |